Ask AI

Breaking News in Obesity Management: The Latest Advances From EASD 2026

Video
This activity is available for 0.25 CME/CE credit(s).

Released: October 28, 2026

Expiration: October 27, 2027

See Activity Collection

Two experts in obesity medicine discuss the key studies presented at the EASD 2026 annual meeting, highlighting what emerging therapies to watch for and why long-term management should be addressed at treatment initiation. Learn how you can incorporate these advances into patient-centered obesity care plans that consider treatment efficacy, safety, maintenance, and adherence; patients’ cardiometabolic risk and preferences; as well as real-world implementation considerations across diverse global settings.

Obesity studies at EASD 2026

Pre Assessment

Assess your current knowledge and clinical approach before beginning your video.
1.

How many people with obesity do you provide care for in a typical week?

2.

For those who practice in academic or community settings, please indicate your practice setting:

3.

How confident are you identifying the obesity data from EASD 2026 most relevant for your patients? 

4.

A 58-yr-old patient with obesity and type 2 diabetes asks how emerging EASD 2026 data on amylin-based and oral therapies might affect treatment planning.

Which approach best reflects appropriate use of these data?